Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 381

1.

Isolation and Characterization of Human Umbilical Cord-derived Mesenchymal Stem Cells from Preterm and Term Infants.

Iwatani S, Yoshida M, Yamana K, Kurokawa D, Kuroda J, Thwin KKM, Uemura S, Takafuji S, Nino N, Koda T, Mizobuchi M, Nishiyama M, Fujioka K, Nagase H, Morioka I, Iijima K, Nishimura N.

J Vis Exp. 2019 Jan 26;(143). doi: 10.3791/58806.

PMID:
30741254
2.

Association of Embolic Sources With Cause-Specific Functional Outcomes Among Adults With Cryptogenic Stroke.

Kiyuna F, Sato N, Matsuo R, Kamouchi M, Hata J, Wakisaka Y, Kuroda J, Ago T, Kitazono T; Fukuoka Stroke Registry Investigators.

JAMA Netw Open. 2018 Sep 7;1(5):e182953. doi: 10.1001/jamanetworkopen.2018.2953.

3.

Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients.

Sasaki N, Shimura K, Yoshida M, Uoshima N, Kiyota M, Hatsuse M, Uchiyama H, Chinen Y, Kobayashi T, Nakao M, Takahashi R, Nakano-Akamatsu S, Kaneko H, Kobayashi Y, Shimazaki C, Taniwaki M, Kuroda J; Kyoto Clinical Hematology Study Group (KOTOSG) investigators.

Int J Hematol. 2019 Jan 9. doi: 10.1007/s12185-018-02583-w. [Epub ahead of print]

PMID:
30627868
4.

Nox4 Promotes Neural Stem/Precursor Cell Proliferation and Neurogenesis in the Hippocampus and Restores Memory Function Following Trimethyltin-Induced Injury.

Yoshikawa Y, Ago T, Kuroda J, Wakisaka Y, Tachibana M, Komori M, Shibahara T, Nakashima H, Nakashima K, Kitazono T.

Neuroscience. 2019 Feb 1;398:193-205. doi: 10.1016/j.neuroscience.2018.11.046. Epub 2018 Dec 5.

PMID:
30528855
5.

Clinical Implications of t(11;14) in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation.

Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, Atsuta Y, Sunami K.

Biol Blood Marrow Transplant. 2018 Nov 10. pii: S1083-8791(18)30696-7. doi: 10.1016/j.bbmt.2018.11.003. [Epub ahead of print]

PMID:
30423479
6.

Dural arteriovenous fistula associated with intratumor hemorrhage.

Takemoto Y, Kawano T, Ohmori Y, Nakagawa T, Ohta K, Kuroda JI, Yano S, Mukasa A.

J Clin Neurosci. 2019 Jan;59:352-355. doi: 10.1016/j.jocn.2018.10.008. Epub 2018 Oct 31.

PMID:
30391309
7.

Prognostic impact of low allelic ratio FLT3-ITD and NPM1 mutation in acute myeloid leukemia.

Sakaguchi M, Yamaguchi H, Najima Y, Usuki K, Ueki T, Oh I, Mori S, Kawata E, Uoshima N, Kobayashi Y, Kako S, Tajika K, Gomi S, Shono K, Kayamori K, Hagihara M, Kanda J, Uchiyama H, Kuroda J, Uchida N, Kubota Y, Kimura S, Kurosawa S, Nakajima N, Marumo A, Omori I, Fujiwara Y, Yui S, Wakita S, Arai K, Kitano T, Kakihana K, Kanda Y, Ohashi K, Fukuda T, Inokuchi K.

Blood Adv. 2018 Oct 23;2(20):2744-2754. doi: 10.1182/bloodadvances.2018020305.

8.

Roles of basal keratinocytes in actinotrichia formation.

Kuroda J, Iwane AH, Kondo S.

Mech Dev. 2018 Oct;153:54-63. doi: 10.1016/j.mod.2018.08.010. Epub 2018 Sep 6.

9.

Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma.

Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Kobayashi T, Abe M, Ishida T, Nagura E, Shimizu K.

Hematol Oncol. 2018 Dec;36(5):792-800. doi: 10.1002/hon.2559. Epub 2018 Sep 19.

PMID:
30176173
10.

Correction to: Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R.

Ann Hematol. 2018 Oct;97(10):2013-2014. doi: 10.1007/s00277-018-3450-2.

PMID:
30046847
11.

Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry.

Nakaya A, Yagi H, Kaneko H, Kosugi S, Kida T, Adachi Y, Shibayama H, Kohara T, Kamitsuji Y, Fuchida SI, Uoshima N, Kawata E, Uchiyama H, Shimura Y, Takahashi T, Urase F, Ohta K, Hamada T, Miyamoto K, Kobayashi M, Shindo M, Tanaka H, Shimazaki C, Hino M, Kuroda J, Kanakura Y, Takaoari-Kondo A, Nomura S, Matsumura I; Kansai Myeloma Forum Investigators.

Leuk Res Rep. 2018 Jul 4;10:7-10. doi: 10.1016/j.lrr.2018.07.001. eCollection 2018.

12.

BCL2 expression is associated with a poor prognosis independent of cellular origin in primary central nervous system diffuse large B-cell lymphoma.

Makino K, Nakamura H, Shinojima N, Kuroda JI, Yano S, Mikami Y, Mukasa A.

J Neurooncol. 2018 Oct;140(1):115-121. doi: 10.1007/s11060-018-2940-3. Epub 2018 Jul 2.

PMID:
29968039
13.

Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2.

Takimoto-Shimomura T, Tsukamoto T, Maegawa S, Fujibayashi Y, Matsumura-Kimoto Y, Mizuno Y, Chinen Y, Shimura Y, Mizutani S, Horiike S, Taniwaki M, Kobayashi T, Kuroda J.

Invest New Drugs. 2018 Jun 21. doi: 10.1007/s10637-018-0623-8. [Epub ahead of print]

PMID:
29931583
14.

Characterization of mannitol granules and powder: A comparative study using two flowability testers.

Takeuchi Y, Tomita T, Kuroda J, Kageyu A, Yonekura C, Hiramura Y, Tahara K, Takeuchi H.

Int J Pharm. 2018 Aug 25;547(1-2):106-113. doi: 10.1016/j.ijpharm.2018.05.061. Epub 2018 May 24.

PMID:
29803796
15.

Human herpesvirus-6 pneumonitis in a patient with follicular lymphoma following immunochemotherapy with rituximab.

Kuwahara-Ota S, Chinen Y, Mizuno Y, Takimoto-Shimomura T, Matsumura-Kimoto Y, Tanba K, Tsukamoto T, Mizutani S, Shimura Y, Kobayashi T, Horiike S, Kuroda J.

Infect Drug Resist. 2018 May 14;11:701-705. doi: 10.2147/IDR.S163686. eCollection 2018.

16.

The Successful Treatment of Metastatic Extraosseous Ewing Sarcoma with Pazopanib.

Mori Y, Kinoshita S, Kanamori T, Kataoka H, Joh T, Iida S, Takemoto M, Kondo M, Kuroda J, Komatsu H.

Intern Med. 2018 Sep 15;57(18):2753-2757. doi: 10.2169/internalmedicine.9879-17. Epub 2018 May 18.

17.

Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.

Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O.

Int J Urol. 2018 Jul;25(7):678-683. doi: 10.1111/iju.13597. Epub 2018 May 11.

PMID:
29752743
18.

Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline.

Takimoto-Shimomura T, Nagoshi H, Maegawa S, Fujibayashi Y, Tsukamoto T, Matsumura-Kimoto Y, Mizuno Y, Chinen Y, Mizutani S, Shimura Y, Horiike S, Taniwaki M, Kobayashi T, Kuroda J.

Cancer Genomics Proteomics. 2018 May-Jun;15(3):213-223.

19.

Risk Prediction of Diabetic Nephropathy via Interpretable Feature Extraction from EHR Using Convolutional Autoencoder.

Katsuki T, Ono M, Koseki A, Kudo M, Haida K, Kuroda J, Makino M, Yanagiya R, Suzuki A.

Stud Health Technol Inform. 2018;247:106-110.

PMID:
29677932
20.

[A Case of Advanced Esophagogastric Junction Cancer Responding to S-1 Neoadjuvant Chemotherapy].

Kuroda J, Aoki H, Kondou N, Sumita T, Itoh K, Agawa S.

Gan To Kagaku Ryoho. 2018 Apr;45(4):688-690. Japanese.

PMID:
29650836
21.

Impact of hematopoietic stem cell transplantation in patients with relapsed or refractory mantle cell lymphoma.

Yamasaki S, Chihara D, Kim SW, Izutsu K, Iwato K, Fukuda T, Uchida N, Amano I, Nakazawa H, Kuroda J, Hashimoto H, Ichinohe T, Kanda Y, Atsuta Y, Suzumiya J, Suzuki R.

Ann Hematol. 2018 Aug;97(8):1445-1452. doi: 10.1007/s00277-018-3318-5. Epub 2018 Apr 2. Erratum in: Ann Hematol. 2018 Oct;97(10):2013-2014.

PMID:
29610968
22.

Detrimental Effects of Insufficient Warfarin Therapy - A Warning Against Imprudent Use of Warfarin for Atrial Fibrillation Patients.

Kuroda J.

Circ J. 2018 Apr 25;82(5):1258-1259. doi: 10.1253/circj.CJ-18-0292. Epub 2018 Mar 31. No abstract available.

23.

Insulin resistance and clinical outcomes after acute ischemic stroke.

Ago T, Matsuo R, Hata J, Wakisaka Y, Kuroda J, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Neurology. 2018 Apr 24;90(17):e1470-e1477. doi: 10.1212/WNL.0000000000005358. Epub 2018 Mar 30.

PMID:
29602916
24.

Safety of antithrombotic therapy for patients with acute ischemic stroke harboring unruptured intracranial aneurysm.

Shono Y, Sugimori H, Matsuo R, Fukushima Y, Wakisaka Y, Kuroda J, Ago T, Kamouchi M, Kitazono T.

Int J Stroke. 2018 Oct;13(7):734-742. doi: 10.1177/1747493018765263. Epub 2018 Mar 15.

PMID:
29543141
25.

Elotuzumab for the Treatment of Relapsed or Refractory Multiple Myeloma, with Special Reference to its Modes of Action and SLAMF7 Signaling.

Taniwaki M, Yoshida M, Matsumoto Y, Shimura K, Kuroda J, Kaneko H.

Mediterr J Hematol Infect Dis. 2018 Feb 15;10(1):e2018014. doi: 10.4084/MJHID.2018.014. eCollection 2018. Review.

26.

Epidermal regulation of bone morphogenesis through the development and regeneration of osteoblasts in the zebrafish scale.

Iwasaki M, Kuroda J, Kawakami K, Wada H.

Dev Biol. 2018 May 15;437(2):105-119. doi: 10.1016/j.ydbio.2018.03.005. Epub 2018 Mar 7.

PMID:
29524434
27.

Bortezomib plus dexamethasone vs thalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Iida S, Wakabayashi M, Tsukasaki K, Miyamoto K, Maruyama D, Yamamoto K, Takatsuka Y, Kusumoto S, Kuroda J, Ando K, Kikukawa Y, Masaki Y, Kobayashi M, Hanamura I, Asai H, Nagai H, Shimada K, Tsukamoto N, Inoue Y, Tobinai K.

Cancer Sci. 2018 May;109(5):1552-1561. doi: 10.1111/cas.13550. Epub 2018 Apr 17.

28.

Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy.

Mizuno Y, Tsukamoto T, Kawata E, Uoshima N, Uchiyama H, Yokota I, Maegawa S, Takimoto T, Tanba K, Matsumura-Kimoto Y, Kuwahara-Ota S, Fujibayashi Y, Yamamoto-Sugitani M, Chinen Y, Shimura Y, Horiike S, Taniwaki M, Kobayashi T, Kuroda J.

Cancer Med. 2018 Mar;7(3):655-664. doi: 10.1002/cam4.1342. Epub 2018 Feb 23.

29.

An adult-onset case of chronic active Epstein-Barr virus infection with fulminant clinical course.

Kaneko H, Taniwaki M, Matsumoto Y, Yoshida M, Shimura K, Fujino T, Uchiyama H, Kuroda J.

J Infect Chemother. 2018 Jun;24(6):479-482. doi: 10.1016/j.jiac.2017.12.021. Epub 2018 Feb 6.

PMID:
29426773
30.

[A Case Report of Gastric Carcinoma with Lymphoid Stroma Differentially Diagnosed from Malignant Lymphoma].

Yamada K, Kosuga T, Okamoto K, Konishi H, Shiozaki A, Fujiwara H, Morimura R, Murayama Y, Kuriu Y, Ikoma H, Nakanishi M, Kuroda J, Kishimoto M, Konishi E, Otsuji E.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1299-1301. Japanese.

PMID:
29394613
31.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
32.

Prognostic impact of a past or synchronous second cancer in diffuse large B cell lymphoma.

Tanba K, Chinen Y, Uchiyama H, Uoshima N, Shimura K, Fuchida S, Kiyota M, Nakao M, Shimura Y, Kobayashi T, Horiike S, Wada K, Shimazaki C, Kaneko H, Kobayashi Y, Taniwaki M, Kuroda J.

Blood Cancer J. 2018 Jan 25;8(1):1. doi: 10.1038/s41408-017-0043-6. No abstract available.

33.

Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).

Ishikawa J, Matsumura I, Kawaguchi T, Kuroda J, Nakamae H, Miyamoto T, Matsuoka KI, Shibayama H, Hino M, Hirase C, Kamimura T, Shimose T, Akashi K, Kanakura Y.

Int J Hematol. 2018 May;107(5):535-540. doi: 10.1007/s12185-018-2401-y. Epub 2018 Jan 23.

PMID:
29362980
34.

Phosphoinositide-dependent protein kinase 1 is a potential novel therapeutic target in mantle cell lymphoma.

Maegawa S, Chinen Y, Shimura Y, Tanba K, Takimoto T, Mizuno Y, Matsumura-Kimoto Y, Kuwahara-Ota S, Tsukamoto T, Kobayashi T, Horiike S, Taniwaki M, Kuroda J.

Exp Hematol. 2018 Mar;59:72-81.e2. doi: 10.1016/j.exphem.2017.12.006. Epub 2017 Dec 26.

PMID:
29287939
35.

Lithium, magnesium and sulfur purification from seawater using an ion chromatograph with a fraction collector system for stable isotope measurements.

Yoshimura T, Araoka D, Tamenori Y, Kuroda J, Kawahata H, Ohkouchi N.

J Chromatogr A. 2018 Jan 5;1531:157-162. doi: 10.1016/j.chroma.2017.11.052. Epub 2017 Nov 24.

PMID:
29198448
36.

Involvement of WNT Signaling in the Regulation of Gestational Age-Dependent Umbilical Cord-Derived Mesenchymal Stem Cell Proliferation.

Iwatani S, Shono A, Yoshida M, Yamana K, Thwin KKM, Kuroda J, Kurokawa D, Koda T, Nishida K, Ikuta T, Fujioka K, Mizobuchi M, Taniguchi-Ikeda M, Morioka I, Iijima K, Nishimura N.

Stem Cells Int. 2017;2017:8749751. doi: 10.1155/2017/8749751. Epub 2017 Sep 12.

37.

Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.

Makino K, Hirai T, Nakamura H, Kuroda JI, Shinojima N, Uetani H, Kitajima M, Yano S.

World Neurosurg. 2018 Apr;112:e1-e6. doi: 10.1016/j.wneu.2017.10.141. Epub 2018 Feb 13.

PMID:
29104150
38.

High-risk follicular lymphomas harbour more somatic mutations including those in the AID-motif.

Tsukamoto T, Nakano M, Sato R, Adachi H, Kiyota M, Kawata E, Uoshima N, Yasukawa S, Chinen Y, Mizutani S, Shimura Y, Kobayashi T, Horiike S, Yanagisawa A, Taniwaki M, Tashiro K, Kuroda J.

Sci Rep. 2017 Oct 25;7(1):14039. doi: 10.1038/s41598-017-14150-0.

39.

Therapeutic approach for relapsed/refractory multiple myeloma: the logic and practice.

Kuroda J.

Rinsho Ketsueki. 2017;58(10):2058-2066. doi: 10.11406/rinketsu.58.2058. Japanese.

PMID:
28978849
40.

Association Between Onset-to-Door Time and Clinical Outcomes After Ischemic Stroke.

Matsuo R, Yamaguchi Y, Matsushita T, Hata J, Kiyuna F, Fukuda K, Wakisaka Y, Kuroda J, Ago T, Kitazono T, Kamouchi M; Fukuoka Stroke Registry Investigators.

Stroke. 2017 Nov;48(11):3049-3056. doi: 10.1161/STROKEAHA.117.018132. Epub 2017 Oct 3.

PMID:
28974631
41.

Molecular imaging using an anti-human tissue factor monoclonal antibody in an orthotopic glioma xenograft model.

Takashima H, Tsuji AB, Saga T, Yasunaga M, Koga Y, Kuroda JI, Yano S, Kuratsu JI, Matsumura Y.

Sci Rep. 2017 Sep 26;7(1):12341. doi: 10.1038/s41598-017-12563-5.

42.

Expression of Master Regulators of T-cell, Helper T-cell and Follicular Helper T-cell Differentiation in Angioimmunoblastic T-cell Lymphoma.

Matsumoto Y, Nagoshi H, Yoshida M, Kato S, Kuroda J, Shimura K, Kaneko H, Horiike S, Nakamura S, Taniwaki M.

Intern Med. 2017 Nov 1;56(21):2851-2856. doi: 10.2169/internalmedicine.8570-16. Epub 2017 Sep 25.

43.

A Case of the nephrotic syndrome in bone marrow transplantation recipient, histologically showing overlapped glomerular lesions of thrombotic microangiopathy and membranous nephropathy.

Masuzawa N, Nishimura A, Kitani T, Tamagaki K, Sugitani M, Nagoshi H, Kuroda J, Konishi E.

Pathol Int. 2017 Dec;67(12):620-625. doi: 10.1111/pin.12589. Epub 2017 Sep 20.

PMID:
28940837
44.

Hairy B-Cell Lymphoproliferative Disorder and its Differential Diagnosis: a Case with Long-Term Follow-Up.

Matsuda K, Matsumoto Y, Yoshida M, Shimura K, Kaneko H, Inaba T, Horiike S, Kuroda J, Taniwaki M.

Mediterr J Hematol Infect Dis. 2017 Sep 1;9(1):e2017054. doi: 10.4084/MJHID.2017.054. eCollection 2017.

45.

Proteasome inhibitors in first-line treatment of transplant-ineligible multiple myeloma patients.

Kuroda J, Shimura Y.

Rinsho Ketsueki. 2017;58(8):999-1005. doi: 10.11406/rinketsu.58.999. Japanese.

PMID:
28883286
46.

Loss of Surfacten® during bolus administration with a feeding catheter.

Fujioka K, Kuroda J, Yamana K, Iijima K, Morioka I.

Pediatr Int. 2017 Nov;59(11):1174-1177. doi: 10.1111/ped.13412.

PMID:
28846833
47.

Long-Term Maintenance of Hematological and Cytogenetic Remission in 5q- Syndrome After Short-Term Administration of Lenalidomide.

Kawaji Y, Kaneko H, Fujino T, Kuwahara S, Ohshiro M, Hirakawa Y, Iwai T, Uchiyama H, Kuroda J, Taniwaki M.

Indian J Hematol Blood Transfus. 2017 Sep;33(3):443-444. doi: 10.1007/s12288-016-0761-0. Epub 2016 Dec 8. No abstract available.

48.

Alpine bogs of southern Spain show human-induced environmental change superimposed on long-term natural variations.

García-Alix A, Jiménez-Espejo FJ, Toney JL, Jiménez-Moreno G, Ramos-Román MJ, Anderson RS, Ruano P, Queralt I, Delgado Huertas A, Kuroda J.

Sci Rep. 2017 Aug 7;7(1):7439. doi: 10.1038/s41598-017-07854-w.

49.

Cognitive function, treatment response to lithium, and social functioning in Japanese patients with bipolar disorder.

Saito S, Fujii K, Ozeki Y, Ohmori K, Honda G, Mori H, Kato K, Kuroda J, Aoki A, Asahi H, Sato H, Shimoda K, Akiyama K.

Bipolar Disord. 2017 Nov;19(7):552-562. doi: 10.1111/bdi.12521. Epub 2017 Jul 10.

PMID:
28691278
50.

Repeated Paradoxical Brain Infarctions in a Patient on Self-Managed Home Hemodialysis Using a Long-Term Indwelling Catheter.

Kiyohara T, Mizoguchi T, Kuroda J, Wakisaka Y, Irie A, Kitaoka C, Fujisaki K, Nakamura U, Tsuruya K, Kitazono T, Ago T.

J Stroke Cerebrovasc Dis. 2017 Sep;26(9):e183-e185. doi: 10.1016/j.jstrokecerebrovasdis.2017.06.004. Epub 2017 Jun 23.

PMID:
28652058

Supplemental Content

Loading ...
Support Center